Skip to content
Recall Observatory FDA recall evidence

Drug product

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01

D-0400-2025

April 25, 2025

Class II

Product summary

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Event
Event 96744
Status
Ongoing
Classification
Class II
Quantity
3
Official record key
drug-enforcement:D-0400-2025

Official wording

Reason: Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Code information: Lot #: 1MP24042, Exp 6/30/26

Distribution pattern: Distributed to Medical Facilities in MS and FL.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.